CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 2.9% on Insider Selling
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 2.9% on Thursday after an insider sold shares in the company. The company traded as low as $42.78 and last traded at $42.22. 282,558 shares ...
Frontiers16h
Host factors in hepatitis B virus: Mechanistic insights and implications for interferon therapy
Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk ...